163 related articles for article (PubMed ID: 34567635)
1. AFM-compatible microfluidic platform for affinity-based capture and nanomechanical characterization of circulating tumor cells.
Deliorman M; Janahi FK; Sukumar P; Glia A; Alnemari R; Fadl S; Chen W; Qasaimeh MA
Microsyst Nanoeng; 2020; 6():20. PubMed ID: 34567635
[TBL] [Abstract][Full Text] [Related]
2. Affinity-Based Microfluidics Combined with Atomic Force Microscopy for Isolation and Nanomechanical Characterization of Circulating Tumor Cells.
Deliorman M; Glia A; Qasaimeh MA
Methods Mol Biol; 2023; 2679():41-66. PubMed ID: 37300608
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking.
Green BJ; Nguyen V; Atenafu E; Weeber P; Duong BTV; Thiagalingam P; Labib M; Mohamadi RM; Hansen AR; Joshua AM; Kelley SO
Anal Chem; 2019 Aug; 91(15):9348-9355. PubMed ID: 31264404
[TBL] [Abstract][Full Text] [Related]
4. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device.
Yin C; Wang Y; Ji J; Cai B; Chen H; Yang Z; Wang K; Luo C; Zhang W; Yuan C; Wang F
Anal Chem; 2018 Mar; 90(6):3744-3751. PubMed ID: 29464943
[TBL] [Abstract][Full Text] [Related]
5. Characterizing circulating tumor cells using affinity-based microfluidic capture and AFM-based biomechanics.
Deliorman M; Glia A; Qasaimeh MA
STAR Protoc; 2022 Jun; 3(2):101433. PubMed ID: 35664257
[TBL] [Abstract][Full Text] [Related]
6. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
7. Identifying cancer origin using circulating tumor cells.
Lu SH; Tsai WS; Chang YH; Chou TY; Pang ST; Lin PH; Tsai CM; Chang YC
Cancer Biol Ther; 2016 Apr; 17(4):430-8. PubMed ID: 26828696
[TBL] [Abstract][Full Text] [Related]
8. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of circulating tumor cells in prostate cancer.
Diamond E; Lee GY; Akhtar NH; Kirby BJ; Giannakakou P; Tagawa ST; Nanus DM
Front Oncol; 2012; 2():131. PubMed ID: 23087897
[TBL] [Abstract][Full Text] [Related]
10. Effect of Varying Expression of EpCAM on the Efficiency of CTCs Detection by SERS-Based Immunomagnetic Optofluidic Device.
Czaplicka M; Niciński K; Nowicka A; Szymborski T; Chmielewska I; Trzcińska-Danielewicz J; Girstun A; Kamińska A
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182636
[TBL] [Abstract][Full Text] [Related]
11. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
[TBL] [Abstract][Full Text] [Related]
12. Multigene model for predicting metastatic prostate cancer using circulating tumor cells by microfluidic magnetophoresis.
Cho H; Chung JI; Kim J; Seo WI; Lee CH; Morgan TM; Byun SS; Chung JS; Han KH
Cancer Sci; 2021 Feb; 112(2):859-870. PubMed ID: 33232539
[TBL] [Abstract][Full Text] [Related]
13. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells.
Hvichia GE; Parveen Z; Wagner C; Janning M; Quidde J; Stein A; Müller V; Loges S; Neves RP; Stoecklein NH; Wikman H; Riethdorf S; Pantel K; Gorges TM
Int J Cancer; 2016 Jun; 138(12):2894-904. PubMed ID: 26789903
[TBL] [Abstract][Full Text] [Related]
14. Simulation and fabrication of an integrating well-aligned silicon nanowires substrate for trapping circulating tumor cells labeled with Fe
Ghafouri V; Badieirostami M; Fathipour M
Bioimpacts; 2022; 12(6):533-548. PubMed ID: 36644542
[No Abstract] [Full Text] [Related]
15. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
Jia M; Mao Y; Wu C; Wang S; Zhang H
Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
[TBL] [Abstract][Full Text] [Related]
16. Combination of antibody-coated, physical-based microfluidic chip with wave-shaped arrays for isolating circulating tumor cells.
Chen H; Cao B; Chen H; Lin YS; Zhang J
Biomed Microdevices; 2017 Sep; 19(3):66. PubMed ID: 28776234
[TBL] [Abstract][Full Text] [Related]
17. Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence.
Garcia J; Barthelemy D; Geiguer F; Ballandier J; Li KW; Aurel JP; Le Breton F; Rodriguez-Lafrasse C; Manship B; Couraud S; Payen L
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475991
[TBL] [Abstract][Full Text] [Related]
18. Spiral shape microfluidic channel for selective isolating of heterogenic circulating tumor cells.
Kwak B; Lee J; Lee J; Kim HS; Kang S; Lee Y
Biosens Bioelectron; 2018 Mar; 101():311-316. PubMed ID: 29055574
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy using the nanotube-CTC-chip: capture of invasive CTCs with high purity using preferential adherence in breast cancer patients.
Loeian MS; Mehdi Aghaei S; Farhadi F; Rai V; Yang HW; Johnson MD; Aqil F; Mandadi M; Rai SN; Panchapakesan B
Lab Chip; 2019 Jun; 19(11):1899-1915. PubMed ID: 31049504
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial.
Autio KA; Dreicer R; Anderson J; Garcia JA; Alva A; Hart LL; Milowsky MI; Posadas EM; Ryan CJ; Graf RP; Dittamore R; Schreiber NA; Summa JM; Youssoufian H; Morris MJ; Scher HI
JAMA Oncol; 2018 Oct; 4(10):1344-1351. PubMed ID: 29978216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
